[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@NewXvg
"@wallstreetbets @WallStreetMav @wallsthated @WallStreetApes @TheRoaringKitty π¨ $NVAX ALERT π¨ NOVAVAX $nvax XX MILLION SHARES SHORT. Thats ONE THIRD of the entire float. π³ Combine that with: πΉ Shah Capital pushing for a SALE today πΉ Sanofi expanding partnership πΉ Chart setup screaming breakout πΉ CIC deal rumors brewing You dont need diamond hands you need a SEATBELT. This isnt a dip this is FUEL. #NVAX #ShortSqueeze #GammaSqueeze #BiotechStocks #BullRun πππ"
X Link @NewXvg 2025-10-14T13:54Z XXX followers, XX engagements
"History repeats itself ($NVAX) novavax $nvax π₯ History doesnt repeat but it sure rhymes.π
Feb 2024: Shah Capital released its 1st open letter Sanofi deal XX days later. π
Oct 2025: 2nd open letter calling for a full sale of $NVAX.In the last X months Shah added 380K shares now holding XXXX M ( 7.2%) doubling down before going public again. πͺShah values $NVAX at $XXX B based on: π $XX B peak sales (Flu/Covid Combo + Matrix-M royalties + pipeline) π΅ Comps trade at XX sales XXX upside from here.And remember: after the last letter came a billion-dollar Sanofi deal. What comes next π$NVAX"
X Link @NewXvg 2025-10-14T17:05Z XXX followers, XXX engagements
"π¨ BREAKING: Novavax delivers again $NVAX just triggered a $25M milestone payment from Sanofi as the EU marketing authorization for Nuvaxovid officially transfers to Sanofi. Sanofi now takes over commercial & regulatory control in Europe and more milestones + royalties ahead for Novavax. π₯ This is real progress not hype. Protein-based tech is here to stay. πͺ #Novavax #Sanofi #NVAX #Biotech #Vaccines #ProteinPower"
X Link @NewXvg 2025-10-07T13:08Z XXX followers, XXX engagements
"π₯ If you follow Shah Capitals logic: π§© Recent $10.5B respiratory deal = $3B peak sales XXX multiple π $NVAX potential = $45B peak sales (Flu/Covid Combo + Matrix-M royalties + pipeline) Thats $1417.5B valuation potential π€― Even conservative = $812B = XXX from here. Shah says: Sell it to Big Pharma and unlock full value. $NVAX = most undervalued biotech on NASDAQ. #NVAX #Biotech #StocksToWatch #ShortSqueeze #GammaSqueeze π"
X Link @NewXvg 2025-10-14T14:47Z XXX followers, XXX engagements
"π₯ If you follow Shah Capitals logic: π§© Recent $10.5B respiratory deal = $3B peak sales XXX multiple π $NVAX potential = $45B peak sales (Flu/Covid Combo + Matrix-M royalties + pipeline) Thats $1417.5B valuation potential π€― Even conservative = $812B = XXX from here. Shah says: Sell it to Big Pharma and unlock full value. $NVAX = most undervalued biotech on NASDAQ. #NVAX #Biotech #StocksToWatch #ShortSqueeze #GammaSqueeze π"
X Link @NewXvg 2025-10-14T14:46Z XXX followers, XX engagements
"π¨ $NVAX novavax $nvax The calm before the storm After massive news πΉ$25M milestone triggered with Sanofi πΉEU authorization transfer complete πΉExpanded Matrix-M rights Novavax is now technically π₯ STRONG BUY π₯ across ALL timeframes (1h 2h 4h daily weekly) β‘ No other biotech has this setup right now: β
Clean balance sheet & cash inflow from Sanofi β
Partnership revenue + royalties pipeline β
Multiple milestones pending ($25M + $75M + up to $200M Matrix-M) β
Short interest still sky-high a potential gamma/short squeeze setup The indicators dont lie: Oscillators BUY Moving Averages STRONG"
X Link @NewXvg 2025-10-08T14:18Z XXX followers, 1014 engagements
"π₯ $NVAX novavax Is History About to RepeatIn April 2024 activist investor Shah Capital (7.11% stake) demanded board changes at $NVAX citing massive undervaluation and structural manipulation.Just weeks later $NVAX announced a major licensing & investment deal with Sanofi ($500M upfront + equity stake).Shah paused their campaign. The market called it a win. But was it just the first moveπ§ Fast forward: Short interest XX% Coiled chart structure New forensic data shows massive spoofing & gamma suppression Buyout chatter resurfaces: whisper range $35$50π Last time pressure led to a 9-figure"
X Link @NewXvg 2025-10-15T14:25Z XXX followers, XXX engagements
"$nvax NOVAVAX π¨ $NVAX is setting up for a monster move. Fundamentals β Sanofi partnership expanding β Shah Capital pushing for a sale β Technicals screaming breakout across all timeframes π Were staring at a potential 5x move from here and IF a deal with CIC comes through the market cap could hit $78B+. #NVAX #Biotech #ShortSqueeze #GammaRamp"
X Link @NewXvg 2025-10-14T13:12Z XXX followers, XXX engagements
"i see this target eoy $nvax novavax covid vaccine sanofi $sny billion dollar deal"
X Link @NewXvg 2025-10-02T08:40Z XXX followers, 2275 engagements
"π₯π $NVAX novavax about to go PARABOLIC ππ₯ Todays sanofi $sny deeper Matrix M news = π FUEL. Chart screaming: higher lows breakout vibes rocket loading. Volume rising MACD flipping bullish the launchpad is set. Next stop πππ #NVAX #Biotech #Stocks #FDA #MoonMission"
X Link @NewXvg 2025-09-30T19:43Z XXX followers, XXX engagements
"Novavax $nvax π₯ If you follow Shah Capitals logic: π§© Recent $10.5B respiratory deal = $3B peak sales XXX multiple π $NVAX potential = $45B peak sales (Flu/Covid Combo + Matrix-M royalties + pipeline) Thats $1417.5B valuation potential π€― Even conservative = $812B = XXX from here. Shah says: Sell it to Big Pharma and unlock full value. $NVAX = most undervalued biotech on NASDAQ. #NVAX #Biotech #StocksToWatch #ShortSqueeze #GammaSqueeze π"
X Link @NewXvg 2025-10-14T14:46Z XXX followers, XXX engagements
"Shah: $nvax Novavax potential XX Billion Shah Capital recommends an immediate formal strategic review for the sale of the company encompassing its extremely valuable Covid/Flu Combo vaccine pipeline assets and Matrix-M adjuvant technology. Novavaxs IP and scientific capabilities will have far greater upside potential in the hands of large capable pharma entity. The recent $XXXX billion respiratory acquisition had $X billion peak sales expectations in 2029. Novavaxs Flu/Covid Vaccine with only one competitor may have higher peak sales in 2029 considering total combined flu/covid sales of $15"
X Link @NewXvg 2025-10-14T14:31Z XXX followers, XXX engagements
"YESSSSSSSSS SANOFI $SNY and $NVAX novavax go in deeper negotiations ACQUISITION NEXT wallstreet biotech"
X Link @NewXvg 2025-09-30T13:22Z XXX followers, XXX engagements
"π¨ $NVAX is setting up for a monster move. Fundamentals β Sanofi partnership expanding β Shah Capital pushing for a sale β Technicals screaming breakout across all timeframes. Were staring at a potential 5x from here. #Biotech #NVAX #ShortSqueeze #GammaRamp"
X Link @NewXvg 2025-10-14T11:33Z XXX followers, XXX engagements
"novavax $nvax 5x from here minimum 𧬠Shah Capital just called for a sale of Novavax calling it massively undervalued. Potential buyers: Sanofi Merck GSK AstraZeneca. Breakout charts β
Takeover rumors β
CIC whispers β
Now imagine what happens when every short position has to cover. A gamma + short squeeze of historic proportions could be next. ππ₯ Shah sees a minimum 5x from here. The market isnt ready. We are. $NVAX πππ #NVAX #Biotech #ShortSqueeze #GammaSqueeze #MatrixM #BullRun"
X Link @NewXvg 2025-10-14T13:47Z XXX followers, XXX engagements
"why so low History repeats itself ($NVAX) π₯ History doesnt repeat but it sure rhymes.π
Feb 2024: Shah Capital released its 1st open letter Sanofi deal XX days later.π
Oct 2025: 2nd open letter calling for a full sale of $NVAX.In the last X months Shah added 380K shares now holding XXXX M ( 7.2%) doubling down before going public again. πͺShah values $NVAX at $XXX B based on: π $XX B peak sales (Flu/Covid Combo + Matrix-M royalties + pipeline) that's 10x from here π΅ Comps trade at XX sales XXX upside from here.And remember: after the last letter came a billion-dollar Sanofi deal. What"
X Link @NewXvg 2025-10-14T17:13Z XXX followers, XX engagements
"We're counting the days when we gonna whitness the biggest shortsqueeze since Gamestop $gme . this is going to be INSANE novavax $nvax MOASS wallstreet nasdaq trading apes stocks @TheRoaringKitty"
X Link @NewXvg 2025-10-08T08:58Z XXX followers, XXX engagements
"π¨ $NVAX novavax BUYOUT RUMORS INTENSIFY: Shah Capital Pushing for a Sale π¨The markets buzzing: multiple sources point to a potential buyout of Novavax in the $35$50 range.πΌ And heres the kicker: SHAH Capital (7.11% ownership) Novavaxs largest independent shareholder is reportedly urging management behind the scenes to explore strategic alternatives including a full acquisition.π§ Why now NVAX trades at $XXXX but is structurally undervalued (see forensic report π) COVID booster demand is resurging globally for 2025/26 Novavax offers the only approved non-mRNA protein-based platform"
X Link @NewXvg 2025-10-15T10:39Z XXX followers, XXX engagements
"NOVAVAX $NVAX BREAKING NEWS BREAKING NEWS COVID MATRIX M VACCCINE VACCINATION"
X Link @NewXvg 2025-10-07T11:19Z XXX followers, XXX engagements